Reference
1. Ettinger KS, Ganry L, Fernandes RP. Oral Cavity Cancer. Oral
Maxillofac Surg Clin North Am. 2019;31(1):13-29.
2. Liviu Feller JL. Oral Squamous Cell Carcinoma: Epidemiology, Clinical
Presentation and Treatment. Journal of Cancer Therapy. 2012;3.
3. Peters TT, Senft A, Hoekstra OS, Castelijns JA, Witte BI, Leemans CR,
et al. Pretreatment screening on distant metastases and head and neck
cancer patients: Validation of risk factors and influence on survival.
Oral Oncol. 2015;51(3):267-71.
4. Ho AS, Kim S, Tighiouart M, Gudino C, Mita A, Scher KS, et al.
Metastatic Lymph Node Burden and Survival in Oral Cavity Cancer. J Clin
Oncol. 2017;35(31):3601-9.
5. Hart RD, Nasser JG, Trites JR, Taylor SM, Bullock M, Barnes D.
Sentinel lymph node biopsy in N0 squamous cell carcinoma of the oral
cavity and oropharynx. Arch Otolaryngol Head Neck Surg.
2005;131(1):34-8.
6. Braams JW, Pruim J, Freling NJ, Nikkels PG, Roodenburg JL, Boering G,
et al. Detection of lymph node metastases of squamous-cell cancer of the
head and neck with FDG-PET and MRI. J Nucl Med. 1995;36(2):211-6.
7. Ross GL, Soutar DS, MacDonald DG, Shoaib T, Camilleri IG, Robertson
AG. Improved staging of cervical metastases in clinically node-negative
patients with head and neck squamous cell carcinoma. Ann Surg Oncol.
2004;11(2):213-8.
8. Oh LJ, Phan K, Kim SW, Low TH, Gupta R, Clark JR. Elective neck
dissection versus observation for early-stage oral squamous cell
carcinoma: Systematic review and meta-analysis. Oral Oncol.
2020;105:104661.
9. Ding Z, Xiao T, Huang J, Yuan Y, Ye Q, Xuan M, et al. Elective Neck
Dissection Versus Observation in Squamous Cell Carcinoma of Oral Cavity
With Clinically N0 Neck: A Systematic Review and Meta-Analysis of
Prospective Studies. J Oral Maxillofac Surg. 2019;77(1):184-94.
10. Alkureishi LW, Burak Z, Alvarez JA, Ballinger J, Bilde A, Britten
AJ, et al. Joint practice guidelines for radionuclide lymphoscintigraphy
for sentinel node localization in oral/oropharyngeal squamous cell
carcinoma. Ann Surg Oncol. 2009;16(11):3190-210.
11. de Bree R, Nieweg OE. The history of sentinel node biopsy in head
and neck cancer: From visualization of lymphatic vessels to sentinel
nodes. Oral Oncol. 2015;51(9):819-23.
12. Glechner A, Wöckel A, Gartlehner G, Thaler K, Strobelberger M,
Griebler U, et al. Sentinel lymph node dissection only versus complete
axillary lymph node dissection in early invasive breast cancer: a
systematic review and meta-analysis. Eur J Cancer. 2013;49(4):812-25.
13. Seenu V, Suhani S, Srivastava A, Parshad R, Mathur S, Kumar R.
Optimization of sentinel lymph node identification techniques in the
Indian setting: A randomized clinical trial. Indian J Cancer.
2019;56(2):114-8.
14. Keski-Säntti H, Kontio R, Törnwall J, Leivo I, Mätzke S, Suominen S,
et al. Sentinel lymph node biopsy or elective neck dissection for
patients with oral squamous cell carcinoma? Eur Arch Otorhinolaryngol.
2008;265 Suppl 1:S13-7.
15. Kim DH, Kim Y, Kim SW, Hwang SH. Usefulness of Sentinel Lymph Node
Biopsy for Oral Cancer: A Systematic Review and Meta-Analysis.
Laryngoscope. 2021;131(2):E459-e65.
16. Yang Y, Zhou J, Wu H. Diagnostic value of sentinel lymph node biopsy
for cT1/T2N0 tongue squamous cell carcinoma: a meta-analysis. Eur Arch
Otorhinolaryngol. 2017;274(11):3843-52.
17. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting
items for systematic reviews and meta-analyses: the PRISMA statement.
Bmj. 2009;339:b2535.
18. Goossen K, Tenckhoff S, Probst P, Grummich K, Mihaljevic AL, Büchler
MW, et al. Optimal literature search for systematic reviews in surgery.
Langenbecks Arch Surg. 2018;403(1):119-29.
19. Flach GB, Bloemena E, Klop WM, van Es RJ, Schepman KP, Hoekstra OS,
et al. Sentinel lymph node biopsy in clinically N0 T1-T2 staged oral
cancer: the Dutch multicenter trial. Oral Oncol. 2014;50(10):1020-4.
20. Fan SF, Zeng ZY, Peng HW, Guo ZM, Wang SL, Zhang Q. Sentinel lymph
node biopsy versus elective neck dissection in patients with cT1-2N0
oral tongue squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral
Radiol. 2014;117(2):186-90.
21. Chung MK, Lee GJ, Choi N, Cho JK, Jeong HS, Baek CH. Comparative
study of sentinel lymph node biopsy in clinically N0 oral tongue
squamous cell carcinoma: Long-term oncologic outcomes between validation
and application phases. Oral Oncol. 2015;51(10):914-20.
22. Carvalho GMd DV, Kohler H, Guimarães A, Crespo A. Sentinel Lymph
Node Biopsy vs. Elective Neck Dissection in Patients with T1/T2 N0 Oral
Squamous Cell Carcinoma: A Matched Pair Analysis. International Journal
of Oral and Craniofacial Science. 2016;2(1):047-51.
23. Hernando J, Villarreal P, Álvarez-Marcos F, García-Consuegra L,
Gallego L, Junquera L. Sentinel node biopsy versus elective neck
dissection. Which is more cost-effective? A prospective observational
study. J Craniomaxillofac Surg. 2016;44(5):550-6.
24. Cramer JD, Sridharan S, Ferris RL, Duvvuri U, Samant S. Sentinel
Lymph Node Biopsy Versus Elective Neck Dissection for Stage I to II Oral
Cavity Cancer. Laryngoscope. 2019;129(1):162-9.
25. Moya-Plana A, Aupérin A, Guerlain J, Gorphe P, Casiraghi O, Mamelle
G, et al. Sentinel node biopsy in early oral squamous cell carcinomas:
Long-term follow-up and nodal failure analysis. Oral Oncol.
2018;82:187-94.
26. Sundaram PS, Subramanyam P. Effectiveness of sentinel lymph node
scintigraphy and intraoperative gamma probing with gold standard
elective neck dissection in patients with N0 oral squamous cell cancers.
Nucl Med Commun. 2019;40(11):1138-47.
27. den Toom IJ, Boeve K, Lobeek D, Bloemena E, Donswijk ML, de Keizer
B, et al. Elective Neck Dissection or Sentinel Lymph Node Biopsy in
Early Stage Oral Cavity Cancer Patients: The Dutch Experience. Cancers
(Basel). 2020;12(7).
28. Garrel R, Poissonnet G, Moyà Plana A, Fakhry N, Dolivet G, Lallemant
B, et al. Equivalence Randomized Trial to Compare Treatment on the Basis
of Sentinel Node Biopsy Versus Neck Node Dissection in Operable T1-T2N0
Oral and Oropharyngeal Cancer. J Clin Oncol. 2020;38(34):4010-8.
29. Hasegawa Y, Tsukahara K, Yoshimoto S, Miura K, Yokoyama J, Hirano S,
et al. Neck Dissections Based on Sentinel Lymph Node Navigation Versus
Elective Neck Dissections in Early Oral Cancers: A Randomized,
Multicenter, and Noninferiority Trial. J Clin Oncol.
2021;39(18):2025-36.
30. Park W, Jin H, Heo Y, Jeong HS, Son YI, Chung MK, et al. Sentinel
Lymph Node Biopsy Versus Elective Neck Dissection: Long-Term Oncologic
Outcomes in Clinically Node-Negative Tongue Cancer. Clin Exp
Otorhinolaryngol. 2022;15(1):107-14.
31. Marco Roberto Seferin FRP, Chin Shien Lin, Ana Kober Nogueira Leite,
Paulo Vitor Sola Gimenes, Rogerio Aparecido Dedivitis, Marco Aurélio
Vamondes Kulcsar, Claudio Roberto Cernea, Leandro Luongo Matos. Sentinel
lymph node biopsy in early oral cavity tumors: evaluation of the
oncologic efficacy compared to elective neck dissection. Archives of
Head and Neck Surgery. 2018;47:e0876.
32. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical
methods for incorporating summary time-to-event data into meta-analysis.
Trials. 2007;8:16.
33. Parmar MK, Torri V, Stewart L. Extracting summary statistics to
perform meta-analyses of the published literature for survival
endpoints. Stat Med. 1998;17(24):2815-34.
34. Zhou J, Guo H, Zhang Y, Liu H, Dou Q. Prognostic significance of
SHP2 (PTPN11) expression in solid tumors: A meta-analysis. PLoS One.
2022;17(1):e0262931.
35. Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan
M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised
studies of interventions. Bmj. 2016;355:i4919.
36. Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I,
et al. RoB 2: a revised tool for assessing risk of bias in randomised
trials. Bmj. 2019;366:l4898.
37. Saleem MI, Peng T, Zhu D, Wong A, Pereira LM, Tham T. Sentinel Lymph
Node Biopsy Versus Elective Node Dissection in Stage cT1-2N0 Oral Cavity
Cancer. Laryngoscope. 2021.
38. Hiraki A, Fukuma D, Nagata M, Shiraishi S, Kawahara K, Matsuoka Y,
et al. Sentinel lymph node biopsy reduces the incidence of secondary
neck metastasis in patients with oral squamous cell carcinoma. Mol Clin
Oncol. 2016;5(1):57-60.
39. Gupta T, Maheshwari G, Kannan S, Nair S, Chaturvedi P, Agarwal JP.
Systematic review and meta-analysis of randomized controlled trials
comparing elective neck dissection versus sentinel lymph node biopsy in
early-stage clinically node-negative oral and/or oropharyngeal squamous
cell carcinoma: Evidence-base for practice and implications for
research. Oral Oncol. 2022;124:105642.
40. Crocetta FM, Botti C, Pernice C, Murri D, Castellucci A, Menichetti
M, et al. Sentinel node biopsy versus elective neck dissection in
early-stage oral cancer: a systematic review. Eur Arch Otorhinolaryngol.
2020;277(12):3247-60.
41. Hernando J, Villarreal P, Alvarez-Marcos F, Gallego L,
García-Consuegra L, Junquera L. Comparison of related complications:
sentinel node biopsy versus elective neck dissection. Int J Oral
Maxillofac Surg. 2014;43(11):1307-12.
42. Pitman KT, Johnson JT, Brown ML, Myers EN. Sentinel lymph node
biopsy in head and neck squamous cell carcinoma. Laryngoscope.
2002;112(12):2101-13.
43. Schilling C, Stoeckli SJ, Haerle SK, Broglie MA, Huber GF, Sorensen
JA, et al. Sentinel European Node Trial (SENT): 3-year results of
sentinel node biopsy in oral cancer. Eur J Cancer. 2015;51(18):2777-84.
44. Network NCC. Head and Neck Cancer. 2022;Version1.2022.
45. Mahieu R, de Maar JS, Nieuwenhuis ER, Deckers R, Moonen C, Alic L,
et al. New Developments in Imaging for Sentinel Lymph Node Biopsy in
Early-Stage Oral Cavity Squamous Cell Carcinoma. Cancers (Basel).
2020;12(10).
46. Kim JH, Ku M, Yang J, Byeon HK. Recent Developments of ICG-Guided
Sentinel Lymph Node Mapping in Oral Cancer. Diagnostics (Basel).
2021;11(5).
47. Tartaglione G, Vigili MG, Rahimi S, Celebrini A, Pagan M, Lauro L,
et al. The impact of superficial injections of radiocolloids and dynamic
lymphoscintigraphy on sentinel node identification in oral cavity
cancer: a same-day protocol. Nucl Med Commun. 2008;29(4):318-22.
48. Nieuwenhuis EJ, Pijpers R, Castelijns JA, Snow GB.
Lymphoscintigraphic details of sentinel lymph node detection in 82
patients with squamous cell carcinoma of the oral cavity and oropharynx.
Nucl Med Commun. 2003;24(6):651-6.
49. Djurisic S, Rath A, Gaber S, Garattini S, Bertele V, Ngwabyt SN, et
al. Barriers to the conduct of randomised clinical trials within all
disease areas. Trials. 2017;18(1):360.
50. Mallen-St Clair J, Alani M, Wang MB, Srivatsan ES. Human
papillomavirus in oropharyngeal cancer: The changing face of a disease.
Biochim Biophys Acta. 2016;1866(2):141-50.